Scaffold Technology Market Size To Reach $4.92 Billion By 2030

Scaffold Technology Market Growth & Trends

The global scaffold technology market size is expected to reach USD 4.92 billion by 2030, expanding at 13.87% CAGR from 2023 to 2030, according to a new study by Grand View Research, Inc. The application of 3D cell cultures is growing as they are efficient in mimicking the in-vivo physiological state of tissues for efficient representation of disease-causing microenvironmental factors.

Furthermore, increasing research focusing on the development of novel hydrogel types including injectable hydrogels, self-healing hydrogels, hybrid hydrogels, and stimuli-responsive hydrogels are expected to open new revenue generation opportunities in the coming years.

In addition, the significant advancements in regenerative medicine and tissue engineering in recent years have increased the adoption of 3D bioprinting for organ and tissue reconstruction procedures. The 3D bioprinting technique is one of the most lucrative advancements in the field of regenerative medicine which can positively affect market growth.

Numerous companies are developing new 3D bio-printed personalized scaffolds for tissue regeneration. For instance, in June 2022, 3D Systems entered a collaboration with United Therapeutics Corporation for the development of novel 3D-printed organ technologies. Similarly, nanofiber scaffolds are gaining traction due to their high surface area-to-volume ratio and their ability to mimic the fibrous structure of the natural extracellular matrix. Such scaffolds provide a suitable microenvironment for cell adhesion and proliferation, which is anticipated to boost their adoption and drive market growth during the forecast period.

Moreover, the COVID-19 pandemic remains a positive catalyst for the market for scaffold technology. Tissue engineering is extensively used for understanding virology and epidemiology, developing in-vitro model systems, and finding efficient therapeutic solutions for dealing with infection. For instance, a study published in the Advanced Healthcare Materials Journal in October 2021 demonstrated the development of a COVID-19 vaccine candidate that employs biomaterial scaffolds as recruitment sites for immune cells for the development of adaptive immunity.

 Request a free sample copy or view report summary: Scaffold Technology Market Report

Scaffold Technology Market Report Highlights

• The hydrogels segment emerged as the most dominant segment and accounted for the largest revenue share of 41.69% in 2022. Technological advancements in the microfabrication techniques used for the creation of hydrogels are expected to fuel the segment growth

• The orthopedics, musculoskeletal, and spine segment held the highest market share of 52.98% in 2022 due to the increasing number of musculoskeletal procedures performed annually worldwide

• North America dominated the scaffold technology industry and accounted for the largest revenue share of 40.44% in 2022. Rising healthcare expenditure and increasing scientific awareness about the latest scaffold technologies are driving the regional market

• The stem cell therapy, regenerative medicine, and tissue engineering segment dominated the market with a share of 66.45% in 2022. The growth is attributed to the growing adoption of scaffold technology for aesthetic and reconstruction surgeries, soft tissue tumor repair, and other applications

• The biotechnology and pharmaceutical organizations segment dominated the market with the largest revenue share of 46.51% in 2022. The growth in the segment is due to the extensive application of scaffold technology by these organizations in tissue engineering fields

Scaffold Technology Market Segmentation

Grand View Research has segmented the global scaffold technology market report based on type, disease type, application, end-use, and region:

Scaffold Technology Type Outlook (Revenue, USD Million, 2018 - 2030)

• Hydrogels

  • Wound Healing

  • 3D Bioprinting

  • Immunomodulation

• Polymeric Scaffolds

• Micropatterned Surface Microplates

• Nanofiber Based Scaffolds 

Scaffold Technology Disease Type Outlook (Revenue, USD Million, 2018 - 2030)

• Orthopedics, Musculoskeletal, & Spine

• Cancer

• Skin & Integumentary

• Dental

• Cardiology & Vascular

• Neurology

• Urology

• GI, Gynecology

• Others

Scaffold Technology Application Outlook (Revenue, USD Million, 2018 - 2030)

• Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering

• Drug Discovery

• Others

Scaffold Technology End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Biotechnology & Pharmaceutical Organizations

• Research Laboratories & Institutes

• Hospitals & Diagnostic Centers

• Others

Scaffold Technology Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in Scaffold Technology Market

• Thermo Fisher Scientific, Inc.

• Merck KGaA

• Tecan Trading AG

• REPROCELL Inc.

• 3D Biotek LLC

• Becton, Dickinson, and Company

• Medtronic

• Xanofi

• Molecular Matrix, Inc.

• Matricel GmbH

• Pelobiotech

• 4titude

• Corning Incorporated

• Akron Biotech

• Avacta Life Sciences Limited.

• Vericel Corporation

• NuVasive, Inc.

• Allergan